Literature DB >> 17679644

CUtLASS confirms CATIE.

Jim Mintz, Alex Kopelowicz.   

Abstract

Mesh:

Substances:

Year:  2007        PMID: 17679644     DOI: 10.1001/archpsyc.64.8.978-a

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


× No keyword cloud information.
  16 in total

1.  Spatial memory deficits in a virtual reality eight-arm radial maze in schizophrenia.

Authors:  Elena A Spieker; Robert S Astur; Jeffrey T West; Jacqueline A Griego; Laura M Rowland
Journal:  Schizophr Res       Date:  2011-12-09       Impact factor: 4.939

Review 2.  Animal models of schizophrenia.

Authors:  C A Jones; D J G Watson; K C F Fone
Journal:  Br J Pharmacol       Date:  2011-10       Impact factor: 8.739

Review 3.  Translation-Focused Approaches to GPCR Drug Discovery for Cognitive Impairments Associated with Schizophrenia.

Authors:  Cassandra J Hatzipantelis; Monica Langiu; Teresa H Vandekolk; Tracie L Pierce; Jess Nithianantharajah; Gregory D Stewart; Christopher J Langmead
Journal:  ACS Pharmacol Transl Sci       Date:  2020-10-28

Review 4.  Evaluating the role of the alpha-7 nicotinic acetylcholine receptor in the pathophysiology and treatment of schizophrenia.

Authors:  Jared W Young; Mark A Geyer
Journal:  Biochem Pharmacol       Date:  2013-07-12       Impact factor: 5.858

Review 5.  Mouse pharmacological models of cognitive disruption relevant to schizophrenia.

Authors:  Jared W Young; Susan B Powell; Mark A Geyer
Journal:  Neuropharmacology       Date:  2011-06-29       Impact factor: 5.250

6.  The mGluR2/3 agonist LY379268 reverses post-weaning social isolation-induced recognition memory deficits in the rat.

Authors:  Caitlin A Jones; Angus M Brown; Dorothee P Auer; Kevin C F Fone
Journal:  Psychopharmacology (Berl)       Date:  2010-07-07       Impact factor: 4.530

Review 7.  Developing treatments for cognitive deficits in schizophrenia: the challenge of translation.

Authors:  J W Young; M A Geyer
Journal:  J Psychopharmacol       Date:  2014-12-16       Impact factor: 4.153

Review 8.  Using the MATRICS to guide development of a preclinical cognitive test battery for research in schizophrenia.

Authors:  Jared W Young; Susan B Powell; Victoria Risbrough; Hugh M Marston; Mark A Geyer
Journal:  Pharmacol Ther       Date:  2009-03-06       Impact factor: 12.310

9.  The atypical antipsychotic risperidone reverses the recognition memory deficits induced by post-weaning social isolation in rats.

Authors:  Allison L McIntosh; Theresa M Ballard; Lucinda J Steward; Paula M Moran; Kevin C F Fone
Journal:  Psychopharmacology (Berl)       Date:  2013-02-09       Impact factor: 4.530

Review 10.  Randomized controlled trials for schizophrenia: study designs targeted to distinct goals.

Authors:  T Scott Stroup; John R Geddes
Journal:  Schizophr Bull       Date:  2008-01-31       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.